Stergiou Angelos M.

President and CEO at SLS

Sold, on record
$570k
Dollars the filings state
Form 4 sales
4
Latest Nov 18, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • SLSSELLAS Life Sciences Group, Inc.President and CEO

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale SLSPlan not stated
    Dec 31 2018

    Sold 23,277 shares at $1.25 ($29k)

    Stergiou Angelos M., President and CEO

    Sold 5.2% of holdings ($563k position)426,858 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale SLSPlan not stated
    Dec 2 +1067 days

    Sold 2,120 shares at $6.25 ($13k)

    Stergiou Angelos M., President and CEO

    Sold 1.7% of holdings ($771k position)121,167 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale SLSPlan not stated
    Dec 5 +368 days

    Sold 6,494 shares at $2.61 ($17k)

    Stergiou Angelos M., President and CEO

    Sold 3.9% of holdings ($439k position)161,689 shares leftFiling

  4. 4 Form 4 sale SLSNo plan
    Nov 18 +1444 days

    Sold 26,606 shares at $19.18 ($510k)

    Stergiou Angelos M., President and CEO

    No 10b5-1 planSold 1.5% of holdings ($33.8M position)1.7M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Stergiou Angelos M.
Source
Nov 18, 2026SLSPresident and CEOForm 4 sale26,606$510k1.5%No planSEC
Dec 5, 2022SLSPresident and CEOForm 4 sale6,494$17k3.9%Plan not statedSEC
Dec 2, 2021SLSPresident and CEOForm 4 sale2,120$13k1.7%Plan not statedSEC
Dec 31, 2018SLSPresident and CEOForm 4 sale23,277$29k5.2%Plan not statedSEC